Sarowitz Steven I purchased $4.6M of ANGX

Sarowitz Steven I purchased 1,000,000 shares of Angel Studios, Inc. (ANGX) at an average of $4.63 ($4.54–$4.64, $4.63M total) across 2 trades over 2026-11-13 to 2026-11-16.

Original reporting
SEC EDGAR · Sarowitz Steven I
Published Nov 17, 2026, 9:08 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 17, 2026, 9:27 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$ANGX
Bullish
medium confidence
Mentioned
$ANGX
Relevance
7/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$ANGXBullishLow
01

Why it matters

The disclosed open-market purchase is a sentiment input for ANGX, but it does not change fundamentals by itself.

02

Market read

Traders may briefly re-rate ANGX sentiment based on the director’s multi-day, ~$4.63M open-market buy, but expect limited follow-through without additional company catalysts.

03

What to watch

No 10b5-1 plan is cited, but the trades span multiple days and do not include any accompanying operational or financial update from Angel Studios.

Relevance 7/10Novelty 6/10Timing: SEC Form 4 filed 2026-11-17, covering purchases from 2026-11-13 to 2026-11-16

Background

The filing is an SEC Form 4 insider transaction for Angel Studios, Inc. (ANGX) by director Steven Sarowitz.

Company-level read

Ticker impact

$ANGXBullishMedium confidence
Context

Angel Studios director Steven Sarowitz bought 1,000,000 shares in open-market trades for about $4.63M, per a fresh SEC Form 4 filing.

Expected impact

Likely limited upside bias as traders note the purchase, but the move should fade without follow-on company news.

Evidence & confidence

The article is a primary-source insider transaction with clear size and timing, yet insider buys alone rarely drive sustained repricing absent earnings, guidance, or corporate actions.

Market effects

Minimal, this is company-specific insider activity with no stated sector-wide catalyst.

None indicated.

None indicated.

Counterpoint

The purchase may reflect diversification or routine liquidity needs rather than a bullish view, especially since the filing does not confirm intent beyond the transaction code.

Key entities

  • Angel Studios, Inc.

    Subject of the Form 4 insider transaction disclosure.

  • Steven I. Sarowitz

    Director who purchased 1,000,000 shares across two open-market trades.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$ANGXMed

Why is Angel Studios stock rallying today?

Angel Studios (ANGX) stock rose 5.2% after confirming its inclusion in the Russell 2000 and 3000 indexes, effective December 14, 2026. The company's CFO highlighted the milestone, noting increased visibility for institutional investors. Analysts rate ANGX a 'Moderate Buy' with a $8.20 price target. The move contrasts with broader market declines, underscoring its company-specific nature.

$ANGXMed

Angel Studios (ANGX) Q3 2026 Earnings Call Transcript

Angel Studios (ANGX) reported Q3 2026 earnings, highlighting 86% year-over-year growth in paying Guild memberships to 2.94 million. The company exceeded its 2026 release goal, with 796 releases by September. Theatrical distribution saw 8 films released in 2025 and 10 planned for 2026, with notable successes like Young Washington and Drummer Boy.

$ANGXMed

Angel Reports Third Quarter 2026 Results

Angel Studios, Inc. (ANGX) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Angel Reports Third Quarter 2026 Results ​ Angel (NYSE: ANGX) announced the following financial results for the quarter ended September 30, 2026: • Delivered total revenue growth of 107.7% year-over-year to $159.0 million in Q3, and 42.4% quarter-over-quarter ● Deliv